Analysis of financial results of MTS for the third quarter
MTS (MOEX: MTSS) — Russian telecommunications company, which builds its own ecosystem.
Overview of companies on the stock market
MTS (MOEX: MTSS) — Russian telecommunications company, which builds its own ecosystem.
SPb-Exchange summed up the results of stock trading in November. Looks like, investors took advantage of the decline in Alibaba shares and increased their share in their portfolios. But the fallen papers of Virgin Galactic do not want to buy. Tesla, Nvidia and Moderna are the most popular Investors traded 1661 issuers in November.
7 December Brazilian fintech ecosystem Nubank (NYSE: NOT) goes public in the US. This business has growth potential, but stocks now look overpriced. When creating the material, sources were used, inaccessible to users from the Russian Federation. We hope, Do you know, what to do.
Nvidia wants to play the Internet of things, but the regulators won't let her. Americans may ban the export of high technology to countries that do not suit them. Amazon wins big on the cloud front. Disclaimer: when we talk about, that something has grown, we mean a comparison with the same quarter a year earlier.
New bonds of Russian regions and companies started trading on the Moscow Exchange in November, shares of the St. Petersburg Stock Exchange, global depositary receipts for Softline shares and shares of 80 foreign companies at once. There are also new exchange mutual funds and ETFs.. Part of the new bonds we do not mention.
Chinese carrier DiDi, providing taxi and car sharing services, in the morning 3 December announced his departure from the New York Stock Exchange to the Hong Kong. Rumors confirmed Possible delisting became known a week ago. Media learned, that Chinese regulators “asked” the company to draw up a plan to leave the American site.
The company introduced the new Snapdragon G3x processor, which can be used by developers of mobile game consoles. "Hot" market This chip will power a device from Razer, which looks like a Nintendo Switch.
Today we have a speculative idea: take stock of game maker Activision Blizzard (NASDAQ: ATVI) based on their rebound after a strong fall. Growth potential and validity: 22% behind 17 months excluding dividends. Why stocks can go up: they fell hard, and the company's business is strong. How do we act: we take shares on 57,28 $. When creating the material, sources were used, inaccessible to users from the Russian Federation. We hope, Do you know, what to do. Without guarantees Our reflections are based on the analysis of the company's business and the personal experience of our investors, but remember: not a fact, that the investment idea will work like this, as we expect. Everything, what we write, are forecasts and hypotheses, not a call to action. To rely on our reflections or not – it's up to you. And what is there with the forecasts of the author of the Study, like this and this, talk about, that the accuracy of target price predictions is low. And that's ok: there are always too many surprises on the stock exchange and accurate forecasts are rarely realized. If the situation were reversed, then funds based on computer algorithms would show results better than people, but alas, they work worse. So we're not trying to build complex models.. The profitability forecast in the article is the author's expectations. We specify this forecast for the landmark. As with the investment idea in general, readers decide for themselves, it is worth trusting the author and focusing on the forecast or not. We love, appreciate,Инвестредакция На чем компания зарабатывает Мы уже публиковали инвестидею по Activision Blizzard — пришло время для новой. The company develops and sells video games. Surely names like Call of Duty or World of Warcraft will seem familiar to someone. According to the annual report, only 30% the company's proceeds are given by the sale of its products. Other 70% fall on subscription, лицензирование и прочие нематериальные …
Investidea: Activision Blizzard, because the games are good Read more
Turning Point Therapeutics (NASDAQ: TPTX) - American biopharmaceutical company, which focuses on the development of new drugs in the field of oncology. The company aims to overcome the key limitations of existing methods of fighting cancer, to expand the possibilities of therapy.
This market is predicted to grow steady. Its size was estimated at 216 billion US dollars in 2020., and expected, that it will reach $350 billion in 2027 at an average annual growth rate 6,1%. According to research, for 2019 approx. 25% women in the United States were not going to have children.